Cellromax Science Co., Ltd. (KOSDAQ:471820)
4,065.00
-40.00 (-0.97%)
At close: Sep 1, 2026
-30.15% (1Y)
| Market Cap | 44.99B -33.8% |
| Revenue (ttm) | 19.60B -16.0% |
| Net Income | 3.07B +45.2% |
| EPS | 273.02 +41.3% |
| Shares Out | 11.04M |
| PE Ratio | 14.93 |
| Forward PE | n/a |
| Dividend | 185.00 (4.53%) |
| Ex-Dividend Date | Jun 29, 2026 |
| Volume | 1,757 |
| Open | 4,040.00 |
| Previous Close | 4,105.00 |
| Day's Range | 4,040.00 - 4,180.00 |
| 52-Week Range | 3,410.00 - 7,690.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |